Guia prático de urticária para grupos especiais de pacientes

Brandão, Larissa Silva; Melo, Janaina Michelle Lima; Dias, Gabriela Andrade; Mansour, Eli; Gonçalves, Rozana de Fátima; De-Alcântara, Carolina Tavares; Campinhos, Fernanda Lugao; Raeder, Daniela Farah Teixeira; Trancoso-Neves, Leila Vieira Borges; Campos, Régis de Albuquerque; Valle, Solange Oliveira Rodrigues; Agondi, Rosana Câmara; França, Alfeu Tavares; Ensina, Luis Felipe Chiaverini.
Arq. Asma, Alerg. Imunol ; 6(2): 197-213, abr.jun.2022. ilus
Artículo en Inglés, Portugués | LILACS | ID: biblio-1400201

Documentos relacionados

  1. Ligelizumab for Chronic Spontaneous Urticaria.
  2. Ligelizumab for Chronic Spontaneous Urticaria.
  3. Ligelizumab for Chronic Spontaneous Urticaria. Reply.
  4. Ligelizumab for Chronic Spontaneous Urticaria. Reply.
  5. Chronic spontaneous urticaria guidelines: What is new?
  6. Do regional geography and race influence management of chronic spontaneous urticaria?
  7. Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020.
  8. Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria.
  9. Total IgE as a biomarker of omalizumab response in chronic spontaneous urticaria: A meta-analysis.
  10. A genome-wide association study of chronic spontaneous urticaria risk and heterogeneity.